• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    JRF Technology Debuts Elderberry Oral Film Strip

    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand

    Researchers Connect Gut Microbiome to Healthy Aging
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    JRF Technology Debuts Elderberry Oral Film Strip

    House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19

    Gelita Discusses Bioactive Collagen Peptides and the E-sports Market

    FrieslandCampina Partners with Cayuga Milk Ingredients to Introduce Milk Proteins in U.S.
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers

    GMP Laboratories of America, Inc.: Addressing Industry Challenges for 25 Years

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    JRF Technology Debuts Elderberry Oral Film Strip

    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    Researchers Connect Gut Microbiome to Healthy Aging

    House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19

    Gelita Discusses Bioactive Collagen Peptides and the E-sports Market

    FrieslandCampina Partners with Cayuga Milk Ingredients to Introduce Milk Proteins in U.S.
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Aiya America (Matcha by Aiya)

    Verdure Sciences

    Nutrition21, LLC

    Vesta Nutra

    Gencor
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Indena USA, Inc.

    AIDP

    Vesta Nutra

    KLK OLEO - Davos Life Science

    Bioenergy Life Science, Inc. (BLS)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    DSHEA Discussion: Assessing Standards for Scientific Evidence

    Adjusting the health claims system could encourage more clinical trials and benefit consumers.

    DSHEA Discussion: Assessing Standards for Scientific Evidence
    Related CONTENT
    • Preparing for FDA’s New Era of Food Safety
    • Engaging Doctors in the Dialogue About ‘DSHEA 2.0’
    • Emerald Health Bioceuticals Partners with Emerson Ecologics to Offer CBD for Practitioners
    • FDA Launches Dietary Supplement Ingredient Advisory List
    • Trade Groups Join Forces for Dietary Supplement Lobby Day
    By Todd Harrison, Venable06.03.19
    As I write this article, there is much buzz within the industry regarding whether it is time for “DSHEA 2.0.” I have been a proponent of updating the Dietary Supplement Health and Education Act (DSHEA) for some time, especially when it comes to marketing claims because of a constant assault by Plaintiff Class Action lawyers.

    It appears to me that courts have failed to give the proper deference that DSHEA was attempting to address by permitting unjustified lawsuits on structure/function claims. The courts seem to forget that in passing DSHEA, Congress explicitly found that “the Federal Government should not impose unreasonable regulatory barriers limiting or slowing the flow of safe products and accurate information to consumers.”1

    Thus, Congress sought to offer consumers greater access to a wider variety of affordable and beneficial dietary supplement products; and also open the market to companies other than large pharmaceutical firms, which until that point were the only entities with resources to conduct human clinical trials on their products.

    The constant lawsuits by Plaintiff attorneys demonstrates exactly the harms DSHEA was intended to prevent: the attempt to impose hurdles upon small companies that would otherwise provide consumers access to beneficial and affordable health products, and information about them.2 To this end, Congress, some courts, the FTC, and the FDA have made clear that evidence other than a randomized clinical trial (RCT) can be considered in substantiating dietary supplement claims.3

    Scientific Standards
    Clinical trials are not always necessary, and even animal and in vitro studies can and should be considered.4 Accordingly, supplement companies follow the law, and FTC and FDA guidance, by relying on many different modes of research to substantiate claims. Yet, some Plaintiff attorneys ignore the purpose behind DSHEA and the fact that double-blind placebo studies are not necessarily required to support product claims.

    Plaintiff attorneys regularly attempt to impose a higher substantiation standard for dietary supplements that is irreconcilable with the statute and agency guidance. Fortunately, some courts are beginning to understand what is required to support product claims and have universally rejected the attempt to raise this standard. For example, in U.S. v. Bayer Corp., the FTC attempted to require that Bayer’s dietary supplement claims be supported by RCTs. The district court denied the government’s motion, holding that the “[FTC] Guidance specifically refutes the [substantiation] standard the Government is seeking to impose.”5 Based on the statements in the guidance, the court concluded that “competent and reliable scientific evidence does not require drug-level clinical trials.”6

    To that end, the substantiation requirement for dietary supplements is that they must be “truthful and not misleading.”7 Notably, the law does not require the type of human clinical research that is required for drugs, and Congress recognized in DSHEA that the traditional RCT model is not appropriate or necessary because “dietary supplements are safe within a broad range of intake, and safety problems with the supplements are relatively rare.”8

    Congress further recognized that clinical trials may not be feasible for dietary supplements, and the health benefits of dietary supplements are incredibly wide ranging and not always capable of being evaluated by specific endpoints through randomized, double-blind clinical studies. Accordingly, by declining to require RCTs to substantiate dietary supplement claims, Congress limited barriers to the supplement industry’s ability to make truthful and scientifically valid claims about its products. As such, nothing—no law, no regulation, no agency-authored industry guidance, no legislative history, and no court holding—requires randomized clinical trials on the final product for dietary supplements, and there is “no fixed formula for the number or type of studies required.”9

    Competent & Reliable
    Thus, FTC guidance makes clear that RCTs are not necessary to support health claims for dietary supplements, and FTC guidance explicitly distinguishes between RCTs—which are not required—and the appropriate standard for health claims for dietary supplements: “competent and reliable scientific evidence.”10

    “Competent and reliable scientific evidence” (referred to herein as CRSE) is defined as “tests, analyses, research, studies, or other evidence based on the expertise of professionals in the relevant area, that have been conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results.”11

    The CRSE standard mandates an assessment of the relevant scientific information as a whole to evaluate whether the claimed benefits can be achieved. By design, the standard covers many different data points that cannot simply be ignored because they are not RCTs. To be competent and reliable, the science does not need to appear in the form of one study, or any study.

    Rather, inferences and correlations may be drawn among different studies.12 Further, courts mandate an analysis of the opinions of qualified experts in the relevant field when determining whether claims are substantiated.13

    Indeed, the only requirement is that the evidence must be viewed in its totality and not in isolation to the other pieces of the puzzle. For sure, the standard allows an advertiser to make health-related claims based upon testing of the product’s ingredients if the claims are connected to the studies upon which it relies.14 For example, in Bayer, the court held that the company possessed competent and reliable scientific evidence to make claims for its probiotic product, even though Bayer relied upon studies concerning the product’s individual ingredients, three active bacteria strands.15 There, the court found that studies for each of the individual bacteria strains satisfied the “competent and reliable scientific evidence” standard to substantiate claims that Bayer’s complete probiotic product could “promote overall digestive health” and “help defend against occasional constipation, diarrhea, gas and bloating.”

    The Garden of Life case similarly permitted health claims on a final product, where substantiation was based upon ingredient studies.16 In sum, both agency guidance and court decisions make clear that whether the CRSE standard has been met looks to the totality of the surrounding science, and requires analysis by qualified experts in the relevant field.17

    Improving the System
    While the standard is quite clear, the issue is that experts may disagree on what the totality of the scientific evidence suggests. Thus, there is always an incentive for Plaintiff attorneys to send demand letters and file lawsuits in the hope of extracting some sort of settlement out of the marketer.

    To be sure, there are bad actors in this industry who make claims that have no reasonable basis. The problem is that many of the lawsuits are brought against companies making legitimate structure/function claims. Part of the issue is there is no government preapproval for claims that would allow defendants to argue preemption.

    While I am not a proponent of all claims being pre-approved, I am in favor of a system that encourages companies to conduct clinical studies on their finished products and submitting those studies to FDA to receive clearance to make certain claims for the products. In return, companies that submit claims to FDA for clearance should be permitted to make not only structure/function claims that are supported by the clinical study and the totality of evidence around the ingredients, but also be allowed to make claims that are consistent with OTC drug indications.

    More importantly, with such a system, all claims cleared by FDA would be considered preempted from being challenged by any other regulatory agency or private party. The program could be funded through a sliding scale of reasonable user fees based on the size of the company. I would not stop there, however; we should also have a monograph system available, similar to what we have with OTC drugs, in which claims for ingredients are developed and permitted without clinical trials on the finished product. However, those claims would be limited to structure/function claims in order to encourage actual studies on finished products. I have proposed this system many times over the years, but with the constant onslaught of frivolous lawsuits it is time to do something to eliminate this risk.

    We can talk about DSHEA 2.0, but the fact is that some areas simply require FDA to enforce the law as written. Claims are the bread and butter of this industry and the system is broken in my opinion; and it’s in need of an update. 

    References
    1. P.L. 103-417, § 2(13), Oct. 25, 1994, 108 Stat. 4334.
    2. See FTC Guidance.
    3. See Dietary Supplement Health & Education Act of 1994 (“DSHEA”), Pub. L. No. 103-417, 108 Stat. 4325; FTC, Dietary Supplements: An Advertising Guide for Industry (issued Nov. 1998), (“FTC Guidance”).
    4. FTC Guidance at 10.
    5. No. 07-cv-01, 2015 WL 5822595 (D.N.J. Sept. 24, 2015), at *14.
    6. Id. See also FTC v. Garden of Life, 845 F. Supp. 2d 1328, 1334-35 (S.D. Fla. 2012), aff’d in part, vacated in part, 516 F. App’x 852 (11th Cir. 2013) (rejecting FTC’s RCT standard for dietary supplements); see also Basic Research, LLC v. FTC, No. 2:09-cv-0779, 2014 WL 12596497 (D. Utah Nov. 25, 2014) (same).
    7. Id. § 343(r)(6)(B).
    8. Pub. L. No. 103- 417, § 2(14), 108 Stat. at 4326.3.
    9. Id. at 8-9.
    10. See, e.g., FTC Guidance at 3; FDA, Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act (Dec. 2008), (“FDA Guidance”) ( “there is no pre-established formula as to how many or what type of studies are needed to substantiate a claim” and recognizes that randomized, double-blind, clinical trials “may not always be possible, practical, or ethical.”). 
    11. FTC Guidance at 9.  See also FDA, Guidance for Industry Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act
    12. Id.
    13. U.S. v. Bayer, 2015 WL 5822595, at *4; Garden of Life, Inc., 845 F. Supp. 2d at 1337-38 (S.D. Fla. 2012); Basic Research, LLC v. FTC, No. 2:09-cv-0779, 2014 WL 12596497, at *5 (D. Utah Nov. 25, 2014).
    14. U.S. v. Bayer Corp., 2015 WL 5822595, at *4; Basic Research, LLC v. F.T.C., 2014 WL 12596497, at *5.
    15. U.S. v. Bayer Corp., No. 07-cv-01, 2015 WL 5822595, at *4 (D.N.J. Sept. 24, 2015). 
    16. FTC. v. Garden of Life, Inc., 845 F. Supp. 2d at 1337-38 (S.D. Fla. 2012). 
    17. U.S. v. Bayer Corp., 2015 WL 5822595, at *4; Garden of Life, 845 F. Supp. 2d 1328, 1337-38; Basic Research, LLC v. F.T.C., 2014 WL 12596497, at *5.

    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Digestive Health
    • Regulation
    • Functional Food
    • Testing
    Related Knowledge Center
    • Regulations
    • Dietary Supplements
    Suggested For You
    Preparing for FDA’s New Era of Food Safety Preparing for FDA’s New Era of Food Safety
    Engaging Doctors in the Dialogue About ‘DSHEA 2.0’ Engaging Doctors in the Dialogue About ‘DSHEA 2.0’
    Emerald Health Bioceuticals Partners with Emerson Ecologics to Offer CBD for Practitioners Emerald Health Bioceuticals Partners with Emerson Ecologics to Offer CBD for Practitioners
    FDA Launches Dietary Supplement Ingredient Advisory List FDA Launches Dietary Supplement Ingredient Advisory List
    Trade Groups Join Forces for Dietary Supplement Lobby Day Trade Groups Join Forces for Dietary Supplement Lobby Day
    Emerging Regulatory Pathways for Nutraceuticals Emerging Regulatory Pathways for Nutraceuticals
    Pet Supplements: A Regulatory Briefing Pet Supplements: A Regulatory Briefing
    Sabinsa Launches LactoSporin for Cosmeceutical Products Sabinsa Launches LactoSporin for Cosmeceutical Products
    FDA Commissioner Scott Gottlieb to Resign FDA Commissioner Scott Gottlieb to Resign
    FDA to Hold Meeting on Regulatory Status of CBD in April FDA to Hold Meeting on Regulatory Status of CBD in April
    Seaweed Extract’s Anti-Cancer Pathways Revealed through In Vitro Study Seaweed Extract’s Anti-Cancer Pathways Revealed through In Vitro Study
    Nutraceutical Brands Find Relief in Outsourcing Manufacturing Nutraceutical Brands Find Relief in Outsourcing Manufacturing
    Research on Stratum Eggshell Membrane Explores Benefits for Cartilage Protection Research on Stratum Eggshell Membrane Explores Benefits for Cartilage Protection
    Algae Breeds New Era of Nutritional Products Algae Breeds New Era of Nutritional Products
    The Magical Mystery Tour Also Known as Cannabis Sativa The Magical Mystery Tour Also Known as Cannabis Sativa

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      The Off-Label On Ramp

      The Off-Label On Ramp

      With an expanding base of clinical research supporting nutritional interventions, off label use of dietary supplements and medical foods is likely to grow.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 01.19.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      ‘Follow the Science’ Often Misses the Mark with Nutrition

      ‘Follow the Science’ Often Misses the Mark with Nutrition

      The mantra too often ignores common sense approaches to improving health and quality of life.
      By Todd Harrison, Venable 01.19.21

    • Dietary Supplements | Herbs & Botanicals | Regulations | World Markets
      CBD in Europe: News from the Front

      CBD in Europe: News from the Front

      A recent decision by the Court of Justice of the European Union has restored CBD’s status, and with it, the prospects of the entire industry.
      By Joerg Gruenwald, analyze & realize ag 01.19.21


    • Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      The Advantages of Organic, Broad Spectrum Hemp

      The Advantages of Organic, Broad Spectrum Hemp

      Mike Hennesy, Wana Brands, discusses the company’s new gummies, innovation, and continuing market evolution.
      By Sheldon Baker 12.04.20

    • Dietary Supplements | Regulations
      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Companies can be prepared by being thorough and transparent while going through insurance policy renewals.
      By Chris Morey, Bolton & Company 12.04.20

    • Dietary Supplements | Regulations
      A Business Perspective on Protecting Confidential Information: The NDA

      A Business Perspective on Protecting Confidential Information: The NDA

      Along with taking precautions in providing access to confidential information, a non-disclosure agreement can be a great way to protect your business.
      By Gregory Stephens, Windrose Partners 11.09.20


    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations | Research | Vitamins
      Using All the Tools to Improve Public Health

      Using All the Tools to Improve Public Health

      Industry needs to make a stand in compelling authorities to communicate the value of nutrition and dietary supplementation.
      By Todd Harrison, Venable 11.09.20

    • Dietary Supplements | Regulations | World Markets
      Regulation Changes Calculus for Substance-Based Medical Devices

      Regulation Changes Calculus for Substance-Based Medical Devices

      The new regulation introduces more specific requirements for the technical documentation of this class of products.
      By Joerg Gruenwald, analyze & realize ag 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      Federal Regulators Slam Doctors for COVID-Related Communications

      Federal Regulators Slam Doctors for COVID-Related Communications

      Some practitioners were not selling or promoting products, they were simply suggesting certain natural substances might offer benefits in improving resilience.
      By Erik Goldman, Holistic Primary Care 10.01.20


    • Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Pet Nutraceuticals
      CBD Dog Health and Fire Flake Farm: Holistic Healing for Furry Friends

      CBD Dog Health and Fire Flake Farm: Holistic Healing for Furry Friends

      Angela Ardolino is a certified cannabis specialist and holistic pet expert who has been caring for animals for over 20 years.
      By Sheldon Baker 10.01.20

    • Dietary Supplements | Regulations
      Nuance Claims? The Red Flags Around False Advertising, Intellectual Property & Mislabeling

      Nuance Claims? The Red Flags Around False Advertising, Intellectual Property & Mislabeling

      If you are a product formulator, label designer, or manufacturing facility, an Errors and Omissions policy is worth exploring.
      By Chris Morey, Bolton & Company 10.01.20

    • Dietary Supplements | Healthcare Trends | Research
      Spotlight on Clinical Research in the COVID-19 Era

      Spotlight on Clinical Research in the COVID-19 Era

      Discerning high quality research evidence from speculation and marketing hype is more important in today’s climate.
      By Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 09.08.20


    • Immune Function | Regulations | Research | Vitamins
      Nutritional Status Has Critical Implications for Public Health

      Nutritional Status Has Critical Implications for Public Health

      Vitamin D, N-acetyl cysteine, and quercetin may have important roles to play in this pandemic.
      By Todd Harrison, Venable 09.08.20

    • Herbs & Botanicals | Regulations | World Markets
      CBD Regulatory Status Update in Europe

      CBD Regulatory Status Update in Europe

      Investing in a novel food application for hemp extracts or CBD derived from hemp is a risky proposition at present.
      By Joerg Gruenwald, analyze & realize ag 09.08.20

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      Potential Pitfalls for Hemp & CBD Products Within Liability Insurance Policies

      Potential Pitfalls for Hemp & CBD Products Within Liability Insurance Policies

      Companies need to account for risks and know what’s covered, but sometimes that’s not a cut-and-dry situation.
      By Chris Morey, Bolton & Company 07.15.20

    Trending
    • Nestlé To Sell North American Water Brands
    • House Resolution Calls For CDC And FDA To Back Vitamin D For COVID-19
    • Innova: Top Trends In Dairy Focus On Holistic Benefits
    • Carlson Launches New Grade Of Astaxanthin Gummies With Astaferm
    • Omega-3s Recommended In Australian Pregnancy Guidelines Update
    Breaking News
    • New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers
    • Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    • JRF Technology Debuts Elderberry Oral Film Strip
    • Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    • Researchers Connect Gut Microbiome to Healthy Aging
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers
    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    OQ Chemicals Increases Carboxylic Acids, Esters Prices
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Thermo Fisher Scientific Completes Mesa Biotech Acquisition
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Clean Beauty Collective Partners with EarthDay.org
    XYZ Registry Launches Beauty-Based Top-Level Domains
    Inahsi Naturals Achieves EU Compliance
    Happi

    Latest Breaking News From Happi

    GUM Recalls Oral Spray
    Sephora To Open More Stores in 2021
    Clean Beauty Collective Supports Earth Day Initiative
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UFlex adds capacity in packaging films
    CEC expands into labels and packaging with Heidelberg
    ABG delivers Digicon Series 3 to UK printer
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Forbes Ranks Rockline Among Best U.S. Employers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login